Dolby Laboratories (DLB) Stock Price & How to Invest
Last updated July 2026
Short answer
Dolby Laboratories (DLB) is a high-margin intellectual-property licensing business that collects royalties whenever its audio and imaging standards (Dolby Atmos, Dolby Vision, Dolby Digital) ship inside TVs, phones, PCs, cars, and streaming services. It trades like a steady, cash-generative franchise rather than a fast grower, so how you view it usually comes down to whether mid-single-digit royalty growth and a ~2.4% dividend fit your goals.
DLB stock price
As of 2026-07-24, Dolby Laboratories (DLB) last closed at $49.86, down 34.7% over the past year. Over the past 52 weeks it has traded between $48.51 and $76.36.
Prices are daily closing prices from Yahoo Finance and may be delayed. For the live quote, check your broker or Dolby Laboratories's investor relations page. Walnut is informational, not investment advice.
What does Dolby Laboratories (DLB) do?
Dolby Laboratories licenses audio and imaging technologies to device makers, content creators, and distributors, earning royalties each time its formats are embedded in hardware or content. Its flagship brands (Dolby Atmos for immersive audio and Dolby Vision for HDR imaging) sit inside televisions, smartphones, PCs, set-top boxes, sound systems, streaming platforms, cinemas, and increasingly automotive infotainment. The model is asset-light: Dolby invests heavily in R&D and standardization, then monetizes the resulting patents and trademarks at very high gross margins once a format reaches critical mass.
The investment picture is one of a mature, profitable franchise rather than a hypergrowth name. Revenue is in the ~$1.35 billion range with net income near $255 million, the balance sheet carries little to no debt and a large cash and investments position, and the company returns capital through a growing dividend and buybacks. Growth is tied to the pace of new-format adoption (Atmos and Vision penetration across TV, mobile, and cars), which drives mid-single-digit royalty gains, offset by lumpy licensing true-ups and consumer-electronics cyclicality that make quarter-to-quarter results uneven.
What's driving Dolby Laboratories (DLB)?
1. Atmos and Vision penetration
The core growth engine is broader adoption of Dolby Atmos and Dolby Vision across TVs, smartphones, PCs, and streaming content. As more devices ship enabled and more titles are mastered in these formats, per-unit and content royalties compound on top of the legacy Dolby Digital base. This shift from foundational codecs toward premium branded formats supports pricing and margin durability.
2. Automotive as a new surface
In-car immersive audio is emerging as a meaningful new licensing surface, with Dolby Atmos designed into premium vehicles such as BMW models. Automotive infotainment expands Dolby's addressable market beyond consumer electronics and streaming, and management has pointed to autos, TV, and mobile as growth contributors behind raised fiscal 2026 guidance.
3. Cash returns and capital allocation
Dolby generates strong free cash flow with minimal debt and a large cash and investments balance, funding a growing dividend (around $1.44 annually, roughly a 2.4% yield) plus ongoing share repurchases. This capital-return profile is a core part of the total-return case and gives the stock a defensive, income-oriented character.
4. Imaging and new-technology optionality
Beyond established formats, Dolby is extending into adjacent imaging, cinema, and live-experience technologies, and continues to sign new partnerships and cinema deployments. These give incremental optionality if newer standards reach scale, though each takes years to move the needle on total revenue.
What are the risks to Dolby Laboratories (DLB)?
Dolby's revenue is concentrated in patent and technology licensing, so expiring patents and the need to keep introducing successful new formats are structural risks to long-term royalty streams. Results are exposed to consumer-electronics cyclicality and are lumpy because of periodic licensing true-ups and catch-up payments, which can swing quarterly comparisons meaningfully. A slowdown in TV, smartphone, or PC unit shipments would directly pressure royalties, and license renewals with major device makers can reset economics. Competition from Xperi/DTS, Sony, and other audio and imaging IP holders, plus the risk that a customer favors royalty-free or in-house alternatives, could erode share over time. Growth is modest, so multiple compression is a risk if the market expects more than mid-single-digit expansion.
How is Dolby Laboratories (DLB) valued? (approximate, July 2026)
A simple financial snapshot. These are approximations and refresh quarterly; for current figures see Dolby Laboratories's investor relations page or your broker.
- Revenue (FY2025): ~$1.35B
- Net income (FY2025): ~$255M
- FY2026 revenue guidance: ~$1.4B-$1.45B
- Market cap: ~$5.9B
- P/E (trailing / forward): ~25x / ~14x
- Dividend (yield): ~$1.44/yr (~2.4%)
Dolby trades at a mid-20s trailing earnings multiple that falls to the mid-teens on forward estimates, reflecting expected fiscal 2026 EPS growth toward the ~$2.66-$2.81 GAAP range. The valuation embeds a steady, high-margin licensing franchise with a strong net-cash balance sheet rather than a rapid grower. The gap between trailing and forward multiples partly reflects licensing true-ups and cyclicality that make single-year comparisons uneven.
Who competes with Dolby Laboratories (DLB)?
Audio and imaging IP licensors
Xperi (parent of DTS) is Dolby's closest head-to-head competitor in home-theater and automotive audio, with Sony, Auro Technologies, and THX also active in immersive-audio and imaging IP. These rivals compete for design wins in the same devices and formats Dolby targets.
Semiconductor and audio-chip vendors
Firms such as Cirrus Logic and Analog Devices supply audio processing silicon and DSP that can substitute for or bypass licensed formats in some designs, pressuring where and how much Dolby can monetize.
Royalty-free and in-house alternatives
Open or royalty-free codecs and platform-owned audio/video standards from large device and streaming companies are an ongoing structural competitor, since manufacturers can choose non-licensed options to avoid royalty costs.
How to invest in Dolby Laboratories (DLB)
There are three common ways to get DLB exposure. Buy shares (or fractional shares) directly at any major broker. Hold an ETF that includes it, which spreads the position across many companies. Or build it into a focused thematic basket, so DLB sits alongside other stocks that express the same thesis.
Walnut takes the basket route. Describe a thesis where DLB fits (for example “AI infrastructure” or “dividend-growth large-caps”) and the AI proposes 5 to 6 constituents with target weights. You review the plan and fund it through your own broker when you're ready.
New to this? Start with how to invest in stocks, see how to analyze a stock with AI, or compare the best AI stock analyzers.
The bottom line on Dolby Laboratories (DLB)
DLB is a durable, cash-rich licensing franchise with a real technology moat and modest growth, priced as a mature compounder rather than a breakout story.
More on Dolby Laboratories (DLB)
Whether DLB is worth buying today depends more on your time horizon and what you already hold than on any single call. We walk through valuation, what would have to go right, and the risks in is DLB a buy?, and where the stock could go from here in the DLB stock forecast.
For income investors, whether DLB pays a dividend and how the payout looks is covered in does DLB pay a dividend?
Build a basket around DLB with Walnut
Use Dolby Laboratories as one constituent in a thematic basket Walnut's AI helps you assemble. Describe a thesis you believe in, the AI proposes the holdings and weights, and you approve before any broker order.
FAQ
What does Dolby Laboratories actually do?
+
Dolby develops audio and imaging technologies (such as Dolby Atmos, Dolby Vision, and Dolby Digital) and licenses them to device makers, content producers, and distributors. It earns royalties when its formats are built into TVs, phones, PCs, cars, streaming services, and cinemas rather than by manufacturing hardware at scale.
How does Dolby make money?
+
The bulk of revenue comes from licensing its intellectual property. Once a format reaches critical mass, Dolby collects high-margin royalties tied to device shipments and content, supplemented by some products and services revenue. The asset-light model produces strong gross margins and free cash flow.
Is DLB profitable?
+
Yes. Dolby has been consistently profitable, with fiscal 2025 net income of roughly $255 million on about $1.35 billion of revenue. It also carries little to no debt and a sizable cash and investments position, which supports its dividend and buybacks.
Does Dolby pay a dividend?
+
Yes. Dolby pays a quarterly dividend totaling roughly $1.44 per share annually, which works out to a yield of about 2.4% at recent prices. The dividend has grown over time and is complemented by ongoing share repurchases.
How fast is Dolby growing?
+
Growth is modest, generally in the mid-single-digit percent range, driven by wider adoption of Atmos and Vision across TVs, mobile, and automotive. Fiscal 2026 revenue guidance of roughly $1.4 billion to $1.45 billion implies continued steady rather than rapid expansion, and results can be lumpy quarter to quarter.
Who are Dolby's main competitors?
+
Its closest rival is Xperi, the parent of DTS, in home-theater and automotive audio. Sony, Auro Technologies, and THX compete in immersive audio and imaging, while chip vendors like Cirrus Logic and royalty-free codecs provide alternative paths that can bypass licensed formats.
What are the biggest risks with DLB?
+
Key risks include patent expirations and the need to keep launching successful new formats, exposure to consumer-electronics cycles, lumpy licensing true-ups that swing quarterly results, license-renewal resets with major customers, and competition from rivals or royalty-free alternatives that could pressure share and pricing.
Why is the stock's forward P/E much lower than its trailing P/E?
+
The forward multiple in the mid-teens reflects expected fiscal 2026 earnings growth toward the ~$2.66 to $2.81 GAAP EPS range, versus a trailing multiple in the mid-20s. Licensing true-ups and year-to-year lumpiness can distort single-year comparisons, so the two multiples can diverge.
Walnut is informational, not investment advice. Financial figures on this page are approximations; always verify current numbers with Dolby Laboratories's investor relations page or your broker before making investment decisions.